The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients

The Effect of Clinically Indicated Liraglutide on Pericoronary Adipose Tissue in Type 2 Diabetic Patients

Vascular inflammation can be detected in the pericoronary adipose tissue (PCAT) by coronary computed tomography angiography (CCTA) attenuation. Treatment with liraglutide is associated with anti-inflammatory effects and reduces cardiovascular risk in diabetic patients. This study is aimed at examini...

Full description

Saved in:

Bibliographic Details
Main Authors:	Irmelin I. A. Biesenbach, Laurits J. Heinsen, Katrine S. Overgaard, Thomas R. Andersen, Søren Auscher, Kenneth Egstrup
Format:	Article
Language:	English
Published:	Wiley 2023-01-01
Series:	Cardiovascular Therapeutics
Online Access:	http://dx.doi.org/10.1155/2023/5126825
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Pericoronary adipose tissue attenuation predicts compositional plaque changes: a 12-month longitudinal study in individuals with type 2 diabetes without symptoms or known coronary artery disease
by: Katrine Schultz Overgaard, et al.
Published: (2025-03-01)

Patient-Level Pericoronary Adipose Tissue Mean Attenuation: Associations with Plaque Characteristics
by: Katrine Schultz Overgaard, et al.
Published: (2024-11-01)

Left Ventricular Systolic Function in Asymptomatic Men Aged 65–75 Years, Relation to Insulin Resistance and Pre-Diabetes: A DANCAVAS Cross-Sectional Sub-Study
by: Johanna Larsson, et al.
Published: (2025-05-01)

High-Risk Plaque Characteristics in Patients with Suspected Stable Coronary Artery Disease and Impaired Glucose Tolerance: A Coronary Computed Tomography Angiography Study
by: Thomas Rueskov Andersen, et al.
Published: (2025-01-01)

Ethnic Differences in Pericoronary Adipose Tissue Attenuation
by: Nitesh Nerlekar, MBBS, MPH, PhD, et al.
Published: (2025-01-01)

The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes
by: Na Zhao, et al.
Published: (2021-01-01)

Prediction of abnormal bone mass with a pericoronary adipose tissue Attenuation model
by: Yanbo Liang, et al.
Published: (2025-04-01)

Identification of patients with unstable angina based on coronary CT angiography: the application of pericoronary adipose tissue radiomics
by: Weisheng Zhan, et al.
Published: (2024-12-01)

Correlation of Sarcopenia with Coronary Artery Disease Severity and Pericoronary Adipose Tissue Attenuation: A Coronary CT Study
by: Domenico Albano, et al.
Published: (2024-10-01)

Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics
by: Jingyue Wang, et al.
Published: (2024-10-01)

Pericoronary adipose tissue radiomics features as imaging markers for coronary artery disease risk assessment: insights from gene expression analysis
by: Yan Li, et al.
Published: (2024-12-01)

Compare the Decrease in Visceral Adipose Tissue in People with Obesity and Prediabetes vs. Obesity and Type 2 Diabetes Treated with Liraglutide
by: Rosa Nayely Hernández-Flandes, et al.
Published: (2025-07-01)

Corrigendum: Evaluating the role of pericoronary adipose tissue on coronary artery disease: insights from CCTA on risk assessment, vascular stenosis, and plaque characteristics
by: Jingyue Wang, et al.
Published: (2024-11-01)

Differentiation of non-ST-segment elevation myocardial infarction from unstable angina using coronary computed tomography angiography: the role of imaging features and pericoronary adipose tissue radiomics
by: Yang Lu, et al.
Published: (2025-06-01)

Visceral Adiposity Index: An Indicator of Adipose Tissue Dysfunction
by: Marco Calogero Amato, et al.
Published: (2014-01-01)

Liraglutide for the treatment of obesity
by: Elmien Bronkhorst, et al.
Published: (2016-05-01)

Remodeling of adipose tissue at experimental diabetes mellitus
by: O. A. Konovalova, et al.
Published: (2013-08-01)

RETRACTED: Therapeutic efficacy of liraglutide on diabetic nephropathy mice by inhibiting inflammatory factors
by: WenXing Fan, et al.
Published: (2018-12-01)

Experience of the use of liraglutide (Victoza) in women with type 2 diabetes mellitus and obesity
by: Vladimir Ivanovich Kudinov, et al.
Published: (2011-06-01)

The Potential Effect of Dapagliflozin and Liraglutide in Attenuating Cardio-Renal Injuries in Diabetic Rats
by: Albanna AA, et al.
Published: (2025-07-01)

Optimizing Osteogenic Differentiation of Ovine Adipose-Derived Stem Cells by Osteogenic Induction Medium and FGFb, BMP2, or NELL1 In Vitro
by: Emil Østergaard Nielsen, et al.
Published: (2018-01-01)

The Effects of Adipose Tissue Dysregulation on Type 2 Diabetes Mellitus
by: Jamie Rausch, et al.
Published: (2025-07-01)

Adipose Tissue Dysfunction and Hepatic Steatosis in New-Onset Diabetes
by: Emilia Rusu, et al.
Published: (2025-07-01)

Mitochondria transplanted adipose-derived stem cells/decellularized adipose tissue hydrogel for adipose tissue regeneration
by: Jiezhang Tang, et al.
Published: (2025-10-01)

Ectopic adipose tissue: association of obesity phenotypes with integral metabolic indices of obesity
by: V. I. Podzolkov, et al.
Published: (2024-07-01)

Beneficial effects of liraglutide on peripheral blood vessels
by: Zhang Xueyang, et al.
Published: (2022-01-01)

Epicardial Adipose Tissue Is Nonlinearly Related to Anthropometric Measures and Subcutaneous Adipose Tissue
by: Miroslav Šram, et al.
Published: (2015-01-01)

Subtraction fractional flow reserve with computed tomography and pericoronary fat attenuation index enhances the identification of revascularization needs in patients
by: Tingting Zhu, et al.
Published: (2025-08-01)

Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus
by: Sara J. Micale, et al.
Published: (2013-01-01)

Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
by: Rosa Bretón‐Romero, et al.
Published: (2018-09-01)

Combined insulin detemir and liraglutide therapy in type 2 diabetic patients: a base for an alliance
by: Lyudmila Alexandrovna Ruyatkina, et al.
Published: (2017-06-01)

Efficacy of liraglutide in patients with metabolic-associated steatotic liver disease in type 2 diabetes mellitus
by: Yu.M. Stepanov, et al.
Published: (2025-06-01)

Impact of liraglutide on albumin-to-creatinine ratio in type 2 diabetes mellitus: a meta-analysis
by: Feng Wang, et al.
Published: (2025-07-01)

Race of GLPS: Impact on Weight and Glycemic Control on Type 2 Diabetes with Semaglutide Versus Liraglutide
by: Noha Hafeez, et al.
Published: (2024-12-01)

Prediction scale of response to liraglutide therapy as the method for increase of treatment efficacy in type 2 diabetes
by: Anna A Mosikian, et al.
Published: (2022-03-01)

White adipose tissue in type 2 diabetes and the effect of antidiabetic drugs
by: Yixuan Zhao, et al.
Published: (2025-04-01)

Advances and challenges of targeting epicardial adipose tissue (EAT) and perivascular adipose tissue (PVAT)
by: Dan Liu, et al.
Published: (2025-08-01)

Long-term effects of duodenal mucosal resurfacing and liraglutide on glycaemic control in patients with type 2 diabetes
by: Max Nieuwdorp, et al.

Manifestations of Adipose Tissue Dysfunction
by: Nicola Abate, et al.
Published: (2013-01-01)

Resolution of Adipose Tissue Inflammation
by: Ana González-Périz, et al.
Published: (2010-01-01)